SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,740,000 | -50.1% | 938,370 | +11.7% | 0.03% | -50.9% |
| Q3 2016 | $51,580,000 | +1794.2% | 839,928 | +488.2% | 0.05% | +1666.7% |
| Q2 2016 | $2,723,000 | +303.4% | 142,806 | +312.9% | 0.00% | +200.0% |
| Q1 2016 | $675,000 | -70.1% | 34,585 | -40.8% | 0.00% | -50.0% |
| Q4 2015 | $2,255,000 | -89.1% | 58,462 | -90.9% | 0.00% | -90.9% |
| Q3 2015 | $20,711,000 | +9.1% | 645,019 | +3.4% | 0.02% | +10.0% |
| Q2 2015 | $18,990,000 | +136.3% | 624,046 | +3.1% | 0.02% | +150.0% |
| Q1 2015 | $8,037,000 | +48.6% | 605,209 | +62.0% | 0.01% | +60.0% |
| Q4 2014 | $5,407,000 | +1010.3% | 373,663 | +1517.9% | 0.01% | – |
| Q3 2014 | $487,000 | -86.4% | 23,096 | -80.8% | 0.00% | -100.0% |
| Q2 2014 | $3,584,000 | +483.7% | 120,321 | +370.8% | 0.00% | +200.0% |
| Q1 2014 | $614,000 | +24.5% | 25,557 | +5.6% | 0.00% | – |
| Q4 2013 | $493,000 | -48.0% | 24,202 | +20.5% | 0.00% | -100.0% |
| Q3 2013 | $948,000 | +31.7% | 20,077 | +6.0% | 0.00% | 0.0% |
| Q2 2013 | $720,000 | – | 18,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |